Study population
The general mean age of the B-ALL patients (60% males and 40% females)
and ITP subjects (55% males and 45% females) was 6.05 ± 3.77 and 5.05
± 3.05 years, respectively. The immunophenotyping and cytogenetics data
of patients are demonstrated in Table 2. Most of the patients expressed
CD3/10/13/19/33/34/79a/ and 117, while the expression of CD2/7/41/ and
61 markers was indicated in fewer patients.